NEJM quickly corrects disclosure statement, errors in diabetes paper

NEJM LogoAfter publishing a paper about neuropathy in diabetic patients last week, The New England Journal of Medicine (NEJM) immediately corrected it after editors learned of errors and some missing disclosures within the article.

The notice explains that the sole author of the paper, “Diabetic Sensory and Motor Neuropathy,” reported incorrect doses for several medications, and received royalties for the tool to measure quality of life used in the paper. The author told us all the declarations were “discussed in detail” between him and the journal, and both parties agreed to the final decision. 

Let’s take a look at the lengthy correction notice — what some of our readers might call a “mega-correction:” Continue reading NEJM quickly corrects disclosure statement, errors in diabetes paper

Two more retractions bring total to 9 for neuroscience duo

Journal of Neuroscience CoverAfter the first author admitted to fraud, his colleagues have retracted a 2013 paper in the Journal of Neuroscience, as well as a 2015 book chapter about working memory.

The retractions come as part of a backstory of pulled papers authored by psychologist Edward Awh and his former graduate student David Anderson when he was based at the University of Oregon in Eugene. The pair retracted four papers last year after Anderson admitted to misconduct during an investigation by the U.S. Office of Research Integrity (and spoke to us about it last July). This led Awh — now based at the University of Chicago in Illinois — to take a second look at the other publications he’d co-authored with Anderson; earlier this year, Awh retracted two others, and informed us more would be coming, including the two most recent publications

First, let’s take a look at the retraction note for the Journal of Neuroscience paper, about remembered items and task performance: Continue reading Two more retractions bring total to 9 for neuroscience duo

How did two papers on same gene with different authors, publishers, end up with identical retraction notices?

1-s2.0-S0006291X16X00058-cov150h1Here’s an interesting case: We’ve found two retracted papers that describe the same gene, and both have nearly identical retraction notices. What’s unusual is that the two papers don’t have any authors in common, and appeared in two different journals published by two different companies.

The cause of both papers’ demise: Plagiarism, and use of unpublished data without permission “from an unnamed source,” who wishes to remain that way. The author of one of the papers confirmed to us that the unnamed source is a “3rd party service company.” Springer told us that the third party in the other paper, however, is another researcher.

It’s a puzzling case, to be sure. We think we have uncovered some of what happened, but remain slightly fuzzy on the details.

Here’s the first retraction, for “KDM3A interacted with p53K372me1 and regulated p53 binding to PUMA in gastric cancer,” originally published online September 30 by Biochemical and Biophysical Research Communications:

Continue reading How did two papers on same gene with different authors, publishers, end up with identical retraction notices?

Mistakes lead to retraction, correction of cancer papers by pair

cover

A series of mistakes have caused a pair of cancer researchers based in China to retract one paper and correct another.

The retraction stems from a duplication of figures in a paper about the molecular underpinnings of colorectal cancer, which the editor of the journal told us he believed was caused by honest error. The other paper was corrected after the authors realized they had published the wrong versions of multiple figures, an error which the authors say does not affect the paper’s conclusions.

This isn’t the first time the pair has had to correct the record — these changes follow a mega-correction for Jie Hong, and Jing-Yuan Fang, both of the Shanghai Jiao-Tong University, where Fang is the director of the Shanghai Institute of Digestive Disease.

Here’s the retraction note for “Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer,” published in the Journal of Pathology:

Continue reading Mistakes lead to retraction, correction of cancer papers by pair

Plant scientist Voinnet’s correction count grows to 22

nature structure molecular biologyWe have found another correction for high-profile plant scientist Olivier Voinnet, bringing his total count to 22. Voinnet, who works at ETH Zurich, also has seven retractions, a funding ban, and a revoked award.

Voinnet’s most recent corrections involve problems with figures; the same issue is cited in this latest correction notice, for “Competition for XPO5 binding between Dicer mRNA, pre-miRNA and viral RNA regulates human Dicer levels.”

The correction notice in Nature Structural & Molecular Biology, issued earlier this year, explains:

Continue reading Plant scientist Voinnet’s correction count grows to 22

Communications researcher loses two book chapters, investigated for plagiarism

BrillA researcher who studies how others communicate is struggling with his own communications: Peter J. Schulz has lost two book chapters for misappropriating the work of others, and is under investigation by his university.

Although the publisher believes the errors were unintentional, the retractions have prompted it to stop selling the books altogether.

Schulz now has a total of three retractions and one erratum for failing to properly cite other works. The University of Lugano in Switzerland, where he is based, told us they’re investigating allegations of plagiarism against him.

Both of the chapters that were recently retracted appear in books published by Brill. The retraction notes say the same thing:

Continue reading Communications researcher loses two book chapters, investigated for plagiarism

Chapter pulled from conference proceedings after authors didn’t attend

978-3-662-47926-1

One of the papers in a book of presentations from a computing conference has been pulled after the editors realized the authors never made it to the meeting.

The book was supposed to comprise papers that were presented at the 2nd International Conference on Harmony Search, an algorithm that finds a vector which optimizes a particular function, based on the way musicians harmonize. So, how did material that wasn’t actually presented at the meeting end up in the volume? A spokesperson for the publisher, Springer, explained:

Continue reading Chapter pulled from conference proceedings after authors didn’t attend

Pharmacology journal pulls paper because third party “compromised” peer review

BJCP CoverThe British Journal of Clinical Pharmacology (BJCP) has retracted a 2015 paper about treating heart failure after deciding its peer review process had been compromised.

This paper is one of the many we’ve noticed lately that have been felled by the actions of a “third party” — in this case, a manuscript editing company called EditPub.

The newly retracted paper, “rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis,” has not yet been cited, according to Thomson Reuters Web of Science.

Here’s the retraction note, which tells us a bit more: Continue reading Pharmacology journal pulls paper because third party “compromised” peer review

Physicists retract Nature paper on Earth’s core after findings aren’t reproducible

cover_naturePhysicists have retracted a highly cited paper from Nature on the behavior of electrons at the center of the Earth after other researchers could not reproduce their findings.

The 2015 paper earned coverage in Science News and Live Science, where co-author Ronald Cohen explained:

There was a big problem in how you generate a magnetic field, and now, because of our results, that problem has basically gone away.

Here are more details about what the original paper claimed, courtesy of a press release from The Carnegie Institution for Science, where co-authors Peng Zhang and Cohen work: Continue reading Physicists retract Nature paper on Earth’s core after findings aren’t reproducible

Cell Press flags two papers after author confesses to fraud

Screen Shot 2016-04-11 at 8.45.56 PMNormally, when we see disputes over fraud allegations, it’s one author accusing another — but an unusual case at Cell has recently crossed our desk.

The journal has flagged a paper after an author confessed to committing fraud himself — but the corresponding author is disputing that confession, citing concerns about the confessor’s “motives and credibility.”

Independent labs are repeating the experiments to determine if the third author on the paper did, as he so claims, manipulate experiments. In the meantime, Cell and Molecular Cell have issued expressions of concern (EOCs) for two papers on which Yao-Yun Liang was a co-author. The notices cite an inquiry at Baylor College of Medicine, where the work was done, which was inconclusive, and recommended the journals take no action about the papers.

The EOCs are pretty much the same (both journals are published by Cell Press). Here’s the EOC that appears on “PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling,” published in 2006 by Cell and cited 251 times, according to Thomson Reuters Web of Science:

Continue reading Cell Press flags two papers after author confesses to fraud